甲状腺癌诊疗的争议与边界  

Controversy and boundary in the diagnose and treatment of thyroid cancer

作　　者：胡清漪 杨柳翠 黄韬[1] Hu Qingyi;Yang Liucui;Huang Tao(Department of Breast and Thyroid Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院甲状腺乳腺外科,武汉430022

出　　处：《中华医学杂志》2024年第18期1566-1571,共6页National Medical Journal of China

摘　　要：近年来甲状腺癌的发病率快速增长,而甲状腺癌的死亡率没有同步增长,因此国内外学者提出甲状腺癌过度诊断的观点,围绕甲状腺癌过度诊疗现象的讨论也日渐激烈。回顾历史、探讨甲状腺癌发病率增长和疗效改善的主要原因,更有利于厘清甲状腺癌真实增长是甲状腺癌发病率增高的最主要原因,而不是过度诊断。同时,也能重新认识哪些因素是甲状腺癌良好疗效的保证。In recent years,the incidence of thyroid cancer has rapidly increased,whereas the mortality rate has not risen correspondingly.Therefore,scholars at home and abroad have proposed the view of overdiagnosis in thyroid cancer,sparking intense debates about the phenomenon of overdiagnosis and overtreatment.A historical review and discussion of the primary reasons for the increase in thyroid cancer incidence and the improvement in treatment outcomes are beneficial.It helps clarify that the real increase in thyroid cancer is primarily due to the higher incidence rate,rather than overdiagnosis.Additionally,it allows us to reevaluate which factors guarantee favorable efficacy in thyroid cancer.

关 键 词：甲状腺肿瘤 发病率 死亡率 过度诊疗 

分 类 号：R736.1[医药卫生—肿瘤]